Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysis
西达本胺联合恩伐利单抗作为对抗 PD-1 疗法耐药的晚期非小细胞肺癌患者的后续治疗:一项具有生物标志物分析的多队列、开放标签、 II 期临床试验
期刊:Cancer Medicine
影响因子:2.9
doi:10.1002/cam4.7175
Yaxiong Zhang, Zihong Chen, Yu Liu, Liang Han, Wei Jiang, Qiming Wang, Jianhua Shi, Liqin Lu, Jianying Li, Mingjun Zhang, Yan Huang, Yunpeng Yang, Xue Hou, Li Zhang, Jing Li, Wenfeng Fang, Gang Chen